Trimethylamine N-oxide in atherogenesis: impairing endothelial self-repair capacity and enhancing monocyte adhesion

Cited by (267)

Items 101–200 of 267

1. Role of Uremic Toxins in Vascular Inflammation Associated with Chronic Kidney Disease
   Rania Chermiti, Stéphane Burtey, Laetitia Dou · 2024 · Journal of Clinical Medicine
2. The gut microbiota in thrombosis
   My Phung Khuu, Nadja Paeslack, Olga Dremova, Corinne Benakis, Klytaimnistra Kiouptsi, Christoph Reinhardt · 2024 · Nature Reviews Cardiology
3. Immune-mediated blood-brain barrier disruption after ischemic stroke: mechanisms and therapeutic targets
   Hanjing Wang, Zhang Yiqiang, Jie Cai, Jiawei Guo · 2025 · Frontiers in Immunology
4. Sugar Fructose Triggers Gut Dysbiosis and Metabolic Inflammation with Cardiac Arrhythmogenesis
   Wanli Cheng, Shao‐Jung Li, Ting-I Lee, Ting‐Wei Lee, Cheng‐Chih Chung, Yu‐Hsun Kao, Yi‐Jen Chen · 2021 · Biomedicines
5. Association of enhanced circulating trimethylamine N‐oxide with vascular endothelial dysfunction in periodontitis patients
   Jiamin Zhou, Shan Chen, Jing Ren, Huiqiong Zou, Yafang Liu, Yanbin Chen, Yumin Qiu, Weijie Zhuang, Jun Tao, Junying Yang · 2021 · Journal of Periodontology
6. Gut Microbiota and Environment in Coronary Artery Disease
   Andrea Piccioni, Tommaso de Cunzo, Federico Valletta, Marcello Covino, Emanuele Rinninella, Pauline Celine Raoul, Christian Zanza, Maria Cristina Mele, Francesco Franceschi · 2021 · International Journal of Environmental Research and Public Health
7. Cracking Brain Diseases from Gut Microbes-Mediated Metabolites for Precise Treatment
   Ying Gong, Anmei Chen, Guohui Zhang, Qing Shen, Liang Zou, Jiahong Li, Yang‐Bao Miao, Weixin Liu · 2023 · International Journal of Biological Sciences
8. Gut microbiota-derived metabolites as immune modulators in aging and age-related chronic inflammatory diseases
   Nan Chen, Carmen K. Chan, Farhan Ullah Khan, Priya Makhijani, Taylor R. Valentino, Shawn Winer, Cynthia T. Luk, Daniel A. Winer · 2026 · Ageing Research Reviews
9. Trimethylamine-N-oxide Specifically Impairs Endothelium-Derived Hyperpolarizing Factor-Type Relaxation in Rat Femoral Artery
   Takayuki Matsumoto, Mihoka Kojima, Keisuke Takayanagi, Kumiko Taguchi, Tsuneo Kobayashi · 2020 · Biological and Pharmaceutical Bulletin
10. How strong is the evidence that gut microbiota composition can be influenced by lifestyle interventions in a cardio-protective way?
    Victor E. A. Gerdes, Miguel Gueimonde, Lotta Pajunen, Max Nieuwdorp, Kirsi Laitinen · 2020 · Atherosclerosis
11. The Role of Gut Microbiota in the Etiopathogenesis of Multiple Chronic Diseases
    Lara Pires, Ana M. Gonzaléz‐Paramás, Sandrina Alves Heleno, Ricardo Costa Calhelha · 2024 · Antibiotics
12. Role of gut microbiota and derived metabolites in cardiovascular diseases
    Jiaqi Yu, Yanan Yang, Weiyao Chen, Jiaxin Hu, Zhechuan Jin, Chongming Wu, Yulong Li · 2025 · iScience
13. Thrombolome and Its Emerging Role in Chronic Kidney Diseases
    Justyna Fryc, Beata Naumnik · 2021 · Toxins
14. Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD)
    Melissa Amrein, Xinmin S. Li, Joan Elias Walter, Zeneng Wang, Tobias Zimmermann, Ivo Strebel, Ursina Honegger, Kathrin Leu, Ibrahim Schäfer, Raphael Twerenbold et al. · 2022 · Clinical Research in Cardiology
15. Effects of REDOX in Regulating and Treatment of Metabolic and Inflammatory Cardiovascular Diseases
    Kai Wang, Yanhan Dong, Jing Liu, Lili Qian, Tao Wang, Xiangqian Gao, Kun Wang, Lu‐Yu Zhou · 2020 · Oxidative Medicine and Cellular Longevity
16. High-circulating gut microbiota-dependent metabolite trimethylamine N-oxide is associated with poor prognosis in pulmonary arterial hypertension
    Yicheng Yang, Qixian Zeng, Jianing Gao, Beilan Yang, Jingjing Zhou, Ke Li, Li Li, Anxin Wang, Xin Li, Zhihong Liu et al. · 2022 · European Heart Journal Open
17. Gut macrobiotic and its metabolic pathways modulate cardiovascular disease
    Junwen Zhu, Jin Lyu, Ruochi Zhao, Gang Liu, Shuangshuang Wang · 2023 · Frontiers in Microbiology
18. Time-dependent specific molecular signatures of inflammation and remodelling are associated with trimethylamine-N-oxide (TMAO)-induced endothelial cell dysfunction
    Meyammai Shanmugham, Arun George Devasia, Yu Ling Chin, Kang Hao Cheong, Eng Shi Ong, Sophie Bellanger, Adaikalavan Ramasamy, Chen Huei Leo · 2023 · Scientific Reports
19. Potential efficacy and mechanism of eight mild-natured and bitter-flavored TCMs based on gut microbiota: A review
    Wenquan Su, Yanan Yang, Xiaohui Zhao, Jiale Cheng, Yuan Li, Shengxian Wu, Chongming Wu · 2023 · Chinese Herbal Medicines
20. The microbiome
    Elvedin Luković, Vivek K. Moitra, Daniel E. Freedberg · 2019 · Current Opinion in Anaesthesiology
21. β-sitosterol inhibits trimethylamine production by regulating the gut microbiota and attenuates atherosclerosis in ApoE–/– mice
    Weiping Wu, Wugao Liu, Huafu Wang, Wei Wang, Weihua Chu, Jing Jin · 2022 · Frontiers in Cardiovascular Medicine
22. Polyphenols from hickory nut reduce the occurrence of atherosclerosis in mice by improving intestinal microbiota and inhibiting trimethylamine N-oxide production
    Chenyu Jiang, Song Wang, Yihan Wang, Ketao Wang, Chunying Huang, Fei Gao, Huang Hu, Yangyong Deng, Wen Zhang, Jian Zheng et al. · 2024 · Phytomedicine
23. Fasting-Mimicking Diet Reduces Trimethylamine N-Oxide Levels and Improves Serum Biochemical Parameters in Healthy Volunteers
    Melita Videja, Eduards Sevostjanovs, Sabīne Upmale-Engela, Edgars Liepinsh, Ilze Konrāde, Maija Dambrova · 2022 · Nutrients
24. TMAO as a Novel Predictor of Major Adverse Vascular Events and Recurrence in Patients with Large Artery Atherosclerotic Ischemic Stroke
    Yanyan Chen, Zusen Ye, Niange Xia, Yun Xu · 2022 · Clinical and Applied Thrombosis/Hemostasis
25. Trimethylamine N-Oxide in Aquatic Foods
    Xiaoyue Li, Chengcheng Wang, Teruyoshi Yanagita, Changhu Xue, Tiantian Zhang, Yuming Wang · 2024 · Journal of Agricultural and Food Chemistry
26. Short-chain fatty acid butyrate against TMAO activating endoplasmic-reticulum stress and PERK/IRE1-axis with reducing atrial arrhythmia
    Tzu-Yu Cheng, Ting‐Wei Lee, Shao‐Jung Li, Ting-I Lee, Yao‐Chang Chen, Yu‐Hsun Kao, Satoshi Higa, Pao‐Huan Chen, Yi-Jen Chen · 2024 · Journal of Advanced Research
27. Microbiome-Derived Trimethylamine N-Oxide (TMAO) as a Multifaceted Biomarker in Cardiovascular Disease: Challenges and Opportunities
    Kinga Jaworska, Wojciech Kopacz, Mateusz Koper, Marcin Ufnal · 2024 · International Journal of Molecular Sciences
28. The correlation between gut microbiome and atrial fibrillation: pathophysiology and therapeutic perspectives
    Na Li, Ling Wang, Lei Li, Meng-Zhao Yang, Qingxiang Wang, Xiwen Bai, Feng Gao, Yiqiang Yuan, Zujiang Yu, Zhigang Ren · 2023 · Military Medical Research
29. Cardiovascular Disease May Be Triggered by Gut Microbiota, Microbial Metabolites, Gut Wall Reactions, and Inflammation
    Leon M. T. Dicks · 2024 · International Journal of Molecular Sciences
30. Fasting Therapy Contributes to the Improvement of Endothelial Function and Decline in Vascular Injury‐Related Markers in Overweight and Obese Individuals via Activating Autophagy of Endothelial Progenitor Cells
    Jiapan Sun, Tingying Zhang, Li Zhang, Bin Ke, Jian Qin · 2020 · Evidence-based Complementary and Alternative Medicine
31. Diabetes Mellitus and Cardiovascular Diseases: Nutraceutical Interventions Related to Caloric Restriction
    Pamela Senesi, Anna Ferrulli, Livio Luzi, Ileana Terruzzi · 2021 · International Journal of Molecular Sciences
32. Trimethylamine N-oxide—a marker for atherosclerotic vascular disease
    Guinan Xie, Yan An, Peng Lin, Yi Wang, Liping Guo · 2021 · Reviews in Cardiovascular Medicine
33. A Novel Insight at Atherogenesis: The Role of Microbiome
    Tatiana Vladimirovna Kirichenko, Yuliya V. Markina, Vasily N. Sukhorukov, Victoria Alexandrovna Khotina, Wei‐Kai Wu, Alexander Nikolaevich Orekhov · 2020 · Frontiers in Cell and Developmental Biology
34. Vascular reactivity stimulated by TMA and TMAO: Are perivascular adipose tissue and endothelium involved?
    Carolina Baraldi A. Restini, Gregory D. Fink, Stephanie Wengert Watts · 2020 · Pharmacological Research
35. The role of the gut microbiome and its metabolites in cerebrovascular diseases
    Hongyu Xu, Ziyue Xu, Shengrong Long, Zhengwei Li, Jiazhi Jiang, Qiangqiang Zhou, Xiaopeng Huang, Xiaohui Wu, Wei Wei, Xiang Li · 2023 · Frontiers in Microbiology
36. Targeting gut microbiota and immune crosstalk: potential mechanisms of natural products in the treatment of atherosclerosis
    Jinpeng Jing, Jing Guo, Rui Dai, Chaojun Zhu, Zhaohui Zhang · 2023 · Frontiers in Pharmacology
37. Trimethylamine N-Oxide (TMAO) and cancer risk: Insights into a possible link
    Biki Saha, Antara Banerjee, Rupak Pathak, Asim K. Duttaroy, Surajit Pathak · 2025 · Biomedicine & Pharmacotherapy
38. Implications of gut microbiome on coronary artery disease
    Jing Xu, Yuejin Yang · 2020 · Cardiovascular Diagnosis and Therapy
39. Gut-Kidney Axis: Unraveling the Role of the Microbiome in Chronic Kidney Disease
    Mihai Rusu, Cristian Ichim, Paula Anderco, Andreea-Daniela Pălăștea, Adrian Boicean · 2026 · Biomedicines
40. Increased Serum Trimethylamine N-Oxide Level in Type 2 Diabetic Patients with Mild Cognitive Impairment
    Nongzhang Xu, Jianwei Wan, Cuihong Wang, Jiatao Liu, Chenqai Qian, Hongyang Tan · 2022 · Diabetes Metabolic Syndrome and Obesity
41. Decreasing of Trimethylamine N-Oxide by Cecal Microbiota and Choline-Trimethylamine Lyase are Associated with Sishen Pill on Diarrhea with Kidney-Yang Deficiency Syndrome
    Mingmin Guo, Yi Wu, Maijiao Peng, Nenqun Xiao, Zhijun Lei, Zhoujin Tan · 2024 · Journal of Inflammation Research
42. Gut microbiota and integrative traditional Chinese and western medicine in prevention and treatment of heart failure
    Herong Cui, Songjie Han, Yanan Dai, Wei Xie, Rui Zheng, Yang Sun, Xiaofeng Xia, Xiaopeng Deng, Yaru Cao, Mei Zhang et al. · 2023 · Phytomedicine
43. Gut microbiota-derived metabolites and chronic inflammatory diseases
    Alejandra Vargas, Benjamin L. Robinson, Kevin Houston, Ana Rosa Vilela Sangay, Michael Saadeh, Steve M. D’Souza, David A. Johnson · 2025 · Exploration of Medicine
44. Trimethylamine‐N‐Oxide Promotes High‐Glucose‐Induced Dysfunction and NLRP3 Inflammasome Activation in Retinal Microvascular Endothelial Cells
    Lidan Xue, Lili Huang, Yajing Tian, Xin Cao, Yu Jin Song · 2023 · Journal of Ophthalmology
45. Trimethylamine N-Oxide Promotes Autoimmunity and a Loss of Vascular Function in Toll-like Receptor 7-Driven Lupus Mice
    Cristina González‐Correa, Javier Moleón, Sofía Miñano, Néstor de la Visitación, Iñaki Robles‐Vera, Manuel Gómez‐Guzmán, Rosario Jiménez, Miguel Romero, Juan Duarte · 2021 · Antioxidants
46. Residual Risk of Trimethylamine‐N‐Oxide and Choline for Stroke Recurrence in Patients With Intensive Secondary Therapy
    Jing Xue, Jie Xu, Mingming Zhao, Aoming Jin, Aichun Cheng, Xue Jiang, Ke Li, Jinxi Lin, Xia Meng, Hao Li et al. · 2022 · Journal of the American Heart Association
47. Gut Microbiota and Heart, Vascular Injury
    Cheng Zeng, Hongmei Tan · 2020 · Advances in experimental medicine and biology
48. Gut microbiota-derived metabolites: Potential targets for cardiorenal syndrome
    Yu-Chen Lai, Yujie Zhu, Xihui Zhang, Shifang Ding, Fang Wang, Jincen Hao, Zhaomeng Wang, Congqi Shi, Yongjin Xu, Lemin Zheng et al. · 2025 · Pharmacological Research
49. The Role of Gut and Airway Microbiota in Pulmonary Arterial Hypertension
    Linlin Huang, Hongdie Zhang, Yijun Liu, Yang Long · 2022 · Frontiers in Microbiology
50. Helicobacter Pylori Infection Induces Intestinal Dysbiosis That Could Be Related to the Onset of Atherosclerosis
    Francisco Avilés‐Jiménez · 2022 · BioMed Research International
51. The human gut microbiome – a new and exciting avenue in cardiovascular drug discovery
    Yu Du, Xingxing Li, Chunyan Su, Li Wang, Jian‐Dong Jiang, Bin Hong · 2019 · Expert Opinion on Drug Discovery
52. Association between risk of preeclampsia and maternal plasma trimethylamine-N-oxide in second trimester and at the time of delivery
    Xin Huang, Zuodong Li, Zhou Gao, Dapeng Wang, Xiaohui Li, Ying Li, Chunmei Mi, Jun Lei · 2020 · BMC Pregnancy and Childbirth
53. Gut Microbiota-Derived Metabolites and Cardiovascular Disease: Focus on Trimethylamine- N -oxide
    Mengxue He, Chin Ping Tan, Yuanfa Liu · 2025 · Journal of Agricultural and Food Chemistry
54. Positive Association of Plasma Trimethylamine-N-Oxide and Atherosclerosis in Patient with Acute Coronary Syndrome
    Wanwen Kong, Junyi Ma, Ying Ni Lin, Weiyu Chen · 2022 · Cardiovascular Therapeutics
55. Intestinal flora: A new target for traditional Chinese medicine to improve lipid metabolism disorders
    Min Liu, Wei Shi, Yefang Huang, Yeke Wu, WU Ke-ming · 2023 · Frontiers in Pharmacology
56. Diet-induced chronic syndrome, metabolically transformed trimethylamine-N-oxide, and the cardiovascular functions
    Shanna J. Hardin, Mahavir Singh, Wintana Eyob, Jack Molnar, Rubens P. Homme, Akash K. George, Suresh C. Tyagi · 2019 · Reviews in Cardiovascular Medicine
57. Related factors based on non-targeted metabolomics methods in minor ischaemic stroke
    Chen Chen, Xiaoyuan Qiao, Jianyong Guo, Ting Yang, Min Wang, Yipeng Ma, Shuhe Zhao, Ling Ding, Hong Liu, Jintao Wang · 2022 · Frontiers in Endocrinology
58. Gut-heart axis: cardiac remodeling and heart failure in the context of inflammatory bowel disease and dysbiosis
    THIERRY KOCHKARIAN, Hania I. Nagy, Qingjie Li · 2025 · American Journal of Physiology-Gastrointestinal and Liver Physiology
59. Trimethylamine N-oxide in cardiovascular disease
    Radosław Konieczny, Wiktor Kuliczkowski · 2022 · Advances in Clinical and Experimental Medicine
60. Network and Experimental Pharmacology on Mechanism of Yixintai Regulates the TMAO/PKC/NF-κB Signaling Pathway in Treating Heart Failure
    Ziyan Wang, Chengxin Liu, Jiaming Wei, Yuan Hui, Min Shi, Fei Zhang, Qinghua Zeng, Aisi Huang, Lixin Du, Ya Li et al. · 2024 · Drug Design Development and Therapy
61. Ethanol: striking the cardiovascular system by harming the gut microbiota
    Carla Brigagão Pacheco da Silva, Jefferson Elias‐Oliveira, Cameron Grant McCarthy, Camilla Ferreira Wenceslau, Daniela Carlos, Rita C. Tostes · 2021 · American Journal of Physiology-Heart and Circulatory Physiology
62. Relationships Among Gut Microbiota, Ischemic Stroke and Its Risk Factors: Based on Research Evidence
    Qinhong Huang, Guannan Cai, Ting Liu, Zhihua Liu · 2022 · International Journal of General Medicine
63. Trimethylamine N-oxide Promotes Atherosclerosis by Regulating Low-Density Lipoprotein-Induced Autophagy in Vascular Smooth Muscle Cells Through PI3K/AKT/mTOR Pathway
    Guixia Shi, Lixiong Zeng, Jialu Shi, Yunhua Chen · 2023 · International Heart Journal
64. A study of the correlation between stroke and gut microbiota over the last 20years: a bibliometric analysis
    Shengnan Han, Longhui Cai, Peipei Chen, Weihong Kuang · 2023 · Frontiers in Microbiology
65. A bacterial metabolite, trimethylamine N-oxide, disrupts the hemostasis balance in human primary endothelial cells but no coagulopathy in mice
    Saravanan Subramaniam, Sarra Boukhlouf, Craig Fletcher · 2019 · Blood Coagulation & Fibrinolysis
66. Dietary choline, via gut microbe- generated trimethylamine-N- oxide, aggravates chronic kidney disease-induced cardiac dysfunction by inhibiting hypoxia-induced factor 1α
    Feifei Xie, Xin Zhen, Zhuoliang Liu, Xiaomei Chen, Zhuanhua Liu, Miaomiao Zhou, Zhanmei Zhou, Zheng Hu, Fengxin Zhu, Qiaobing Huang et al. · 2022 · Frontiers in Physiology
67. Gut microbiota and hypertension: a bibliometric analysis of recent research (2014–2023)
    Yang Jiao, Wenxing Li, Qianyi Zhang, Qianfeng Jiang · 2023 · Frontiers in Nutrition
68. Novel cardiac biomarkers and multiple-marker approach in the early detection, prognosis, and risk stratification of cardiac diseases
    Syed Faqeer Hussain Bokhari, Muhammad Umais, Syed Muhammad Faizan Sattar, Uzma Mehboob, Asma Iqbal, Maaz Amir, Danyal Bakht, Khawar Ali, Abdul Haseeb Hasan, Muhammad Arsham Javed et al. · 2025 · World Journal of Cardiology
69. Liuwei Dihuang formula ameliorates perimenopausal atherosclerosis by modulating the microbiota-dependent TMA-TMAO metabolic axis
    Shurui Zhang, Han Feng, Jingting Jiang, Sunye Feng, Yujie Jiang, Guangjian Chen, Yunjie Wu, Ronghui Liu, Yuxin Ma, Yuting Ma et al. · 2025 · Phytomedicine
70. Trimethylamine N-oxide aggravates vascular permeability and endothelial cell dysfunction under diabetic condition: in vitro and in vivo study
    Jiayi Jiang, Qiuping Zhang, Hang Ren, Qing-Ying Yao, Gaoqin Liu, Peirong Lu · 2023 · International Journal of Ophthalmology
71. Gut microbiota: a novel strategy affecting atherosclerosis
    Lingshuang Yang, Juan Yang, Tiantian Zhang, Xinqiang Xie, Qingping Wu · 2025 · Microbiology Spectrum
72. A systematic review of TMAO, microRNAs, and the oral/gut microbiomes in atherosclerosis and myocardial infarction: mechanistic insights and translational opportunities
    Luigi Regenburgh De La Motte, Fabiana Giarritiello, Lucia La Sala, Lorenzo Drago · 2025 · Journal of Translational Medicine
73. Gut–Kidney–Heart: A Novel Trilogy
    Mario Caldarelli, Laura Franza, Pierluigi Rio, Antonio Gasbarrini, Giovanni Gambassi, Rossella Cianci · 2023 · Biomedicines
74. Microbiome in Behcet's syndrome
    Alessandra Bettiol, Giacomo Emmi, Liying Low, Francesco Sofi, Graham R. Wallace · 2023 · Clinical Immunology
75. Microbial Metabolites and Cardiovascular Dysfunction: A New Era of Diagnostics and Therapy
    Jitendra Kumar · 2025 · Cells
76. Role of Gut Microbiome in Atherosclerosis: Molecular and Therapeutic Aspects
    Juan Salazar, Valery Morillo, M Suarez, Ana Valéria Castro, Paola Ramírez, Milagros Rojas, Roberto Áñez, Luis D’Marco, Maricarmen Chacín, Valmore Bermúdez · 2023 · Current Cardiology Reviews
77. Mechanistic Review on the Role of Gut Microbiota in the Pathology of Cardiovascular Diseases
    Iqra Usman, Aamir Anwar, Shivang Shukla, Priya Pathak · 2024 · Cardiovascular & Haematological Disorders - Drug Targets
78. TMAO induces pyroptosis of vascular endothelial cells and atherosclerosis in ApoE−/− mice via MBOAT2-mediated endoplasmic reticulum stress
    Bo Yu, Chuchu Yuan, Jinna Chen, Zhixiang Zhou, Yile Zhang, Ming Su, Dangheng Wei, Peng Wu · 2024 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
79. The Association of Plasma Trimethylamine N-Oxide with Coronary Atherosclerotic Burden in Patients with Type 2 Diabetes Among a Chinese North Population
    Na Yu, Nan Gu, Yuxin Wang, Bin Zhou, Difei Lu, Jianping Li, Xiaowei Ma, Junqing Zhang, Xiaohui Guo · 2022 · Diabetes Metabolic Syndrome and Obesity
80. Therapeutic potential of traditional Chinese medicine against atherosclerosis: Targeting trimethylamine N-oxide
    Peng Zhou, Jun-li Kang, Qiqing Cheng, Mingtai Chen, Ying Xie, Hua Zhou · 2022 · Phytomedicine
81. Gut Microbiota and Metabolism
    Nevin İlhan · 2018 · International journal of medical biochemistry/International journal of medical biochemistry :
82. Cardiovascular Diseases and Pharmacomicrobiomics: A Perspective on Possible Treatment Relevance
    Lavinia Curini, Amedeo Amedei · 2021 · Biomedicines
83. Association of the trimethylamine N-oxide with cardiovascular risk and vascular alterations in middle-aged patients with risk factors for cardiovascular diseases
    Natalia Spasova, Desislava Somleva, Bozhidar Krastev, Radostina Ilieva, Angelina Borizanova, Dobrin Avramov Svinarov, Elena Kinova, Assen Goudev · 2024 · Bioscience Reports
84. The Non-Traditional Cardiovascular Culprits in Chronic Kidney Disease: Mineral Imbalance and Uremic Toxin Accumulation
    Yue Lu, Linlin Meng, Xinlu Wang, Yun Zhang, Cheng Zhang, Meng Zhang · 2025 · International Journal of Molecular Sciences
85. Gut Microbiota Composition and Metabolites as the new Determinants of Cardiovascular Pathology Development
    Oksana M. Drapkina, A. N. Kaburova · 2020 · Rational Pharmacotherapy in Cardiology
86. Dietary Patterns, Gut Microbiota Remodeling, and Cardiometabolic Disease
    Letizia Guiducci, Giuseppina Nicolini, Francesca Forini · 2023 · Metabolites
87. The origin of trimethylamine- N-oxide (TMAO) and its role in development of atherosclerosis
    Zouyan He, Zhen‐Yu Chen · 2018 · Journal of Food Bioactives
88. A new perspective in intestinal microecology: lifting the veil of exercise regulation of cardiometabolic diseases
    Can Gao, Jinwen Wei, Changxu Lu, Lijie Wang, Dan Feng Dong, Mingli Sun · 2024 · Gut Microbes
89. Gut Molecules in Cardiometabolic Diseases: The Mechanisms behind the Story
    Andreea-Ioana Inceu, Maria Adriana Neag, Anca Elena Craciun, Anca Dana Buzoianu · 2023 · International Journal of Molecular Sciences
90. Blood Metabolomic Phenotyping of Dry Cows Could Predict the High Milk Somatic Cells in Early Lactation—Preliminary Results
    Klevis Haxhiaj, Zhili Li, Mathew Johnson, Suzanna M. Dunn, David Scott Wishart, Burim Namik Ametaj · 2022 · Dairy
91. Physiopathological mechanisms involved in the development of hypertension associated with gut dysbiosis and the effect of nutritional/pharmacological interventions
    Virna Margarita Martín Giménez, Natalia L. Rukavina Mikusic, Hyun Jin Lee, Sebastián García Menéndez, Marcelo R. Choi, Walter A. Manucha · 2022 · Biochemical Pharmacology
92. The role of gut microbiota in cardiovascular diseases and their potential as novel therapeutic targets
    Tomoya Yamashita · 2025 · Journal of Cardiology
93. Human microbiome and cardiovascular diseases
    Jahangir Alam, Vaishnavi Puppala, Shravan Kumar Uppulapu, Bhabatosh Das, S. Banerjee · 2022 · Progress in molecular biology and translational science
94. Plasma Choline as a Diagnostic Biomarker in Slow Coronary Flow
    Yuanting Zhu, Lingping Zhu, Zhenyu Wang, Xueting Qiu, Wanzhou Wu, Wei-Wang Liu, Yu-yu Feng, Wenkai Xiao, Xin Luo, Zhenyu Li et al. · 2020 · Cardiology Research and Practice
95. The association between trimethylamine N-oxide levels and coronary microvascular dysfunction and prognosis in patients with ST-elevation myocardial infarction
    Ali Aldujeli, Tsung‐Ying Tsai, Ayman Haq, Vacis Tatarūnas, Scot Garg, Diarmaid Hughes, Ieva Čiapienė, Ramūnas Unikas, Faisal Sharif, Vaiva Lesauskaitė et al. · 2024 · Atherosclerosis
96. Gut microbiota’s role in heart failure
    Kamila Florek, Katarzyna Komorowska, Jakub Ptak, Michał Jarocki, Joanna Gontarczyk, Roksana Mania, Anna Boluk, Ewa Żurawska-Płaksej, Łukasz Łaczmański, Mateusz Sokolski · 2025 · Heart Failure Reviews
97. Breaking bugs: gut microbes metabolize dietary components and modulate vascular health
    Adhini Kuppuswamy Satheesh Babu, Harini Srinivasan, Pon Velayutham Anandh Babu · 2023 · Critical Reviews in Food Science and Nutrition
98. The Role of Gut Microbiota and Associated Compounds in Cardiovascular Health and its Therapeutic Implications
    Lu Liu, Guneet Inder Jit Kaur, Avinash Kumar, Abhinav Kanwal, Shailendra Pratap Singh · 2024 · Cardiovascular & Hematological Agents in Medicinal Chemistry
99. Impact of Hypoxia–Hyperoxia Exposures on Cardiometabolic Risk Factors and TMAO Levels in Patients with Metabolic Syndrome
    Afina Bestavashvili, Oleg Stanislavovich Glazachev, Shabnam I. Ibragimova, А. Yu. Suvorov, Alexandros Bestavasvili, Shevket Girey Ibraimov, Xinliang Zhang, Yong Zhang, Chavdar S Pavlov, Е. А. Сыркина et al. · 2023 · International Journal of Molecular Sciences
100. Endothelial dysfunction in atherosclerosis: from classical pathways to emerging mechanisms
     Yuyao Feng, Chenyang Li, Junye Chen, Xingqi Xiao, Qi Mao, Hongmei Zhao, Jing Wang, Bao Liu · 2025 · Vessel Plus